CIK: 0001542294
申报总市值
US$2.4亿
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XONUSD | Intrexon CORP | 股票-其他 | 80.93% | — | +0.20% | |
| 2 | HALO | Halozyme Therapeutics INC | 股票-医疗保健 | 10.86% | — | — | |
| 3 | ✓ | Alaunos Therapeutics INC | 股票-其他 | 2.54% | — | — | |
| 4 | EPD | Enterprise Products Partners | 股票-能源 | 1.33% | — | — | |
| 5 | ✓ | Synthetic Biologics INC | 股票-其他 | 1.06% | — | — | |
| 6 | ET | Energy Transfer LP | 股票-能源 | 0.59% | — | — | |
| 7 | ✓ | Fibrocell Science INC | 股票-其他 | 0.56% | — | — | |
| 8 | ✓ | Histogenics CORP | 股票-其他 | 0.40% | — | — | |
| 9 | GEL | Genesis Energy L.p. | 股票-其他 | 0.38% | — | — | |
| 10 | ✓ | Oragenics INC | 股票-其他 | 0.33% | — | — | |
| 11 | NSUSD | Nustar Energy LP | 股票-其他 | 0.27% | — | — | |
| 12 | TCP | Tc Pipelines LP | 股票-其他 | 0.26% | — | — | |
| 13 | ET | Energy Transfer LP | 股票-能源 | 0.15% | — | — | |
| 14 | ✓ | Ovascience INC | 股票-其他 | 0.12% | — | — | |
| 15 | ✓ | Ampliphi Biosciences | 股票-其他 | 0.11% | — | +36.98% | |
| 16 | ✓ | Transgenomic INC | 股票-其他 | 0.10% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | HALO | Halozyme Therapeutics INC | +2.2% | — | 不变 |
| 2 | XONUSD | Intrexon CORP | +1.5% | +0.20% | 加仓 |
| 3 | ✓ | Histogenics CORP | +0.2% | — | 不变 |
| 4 | ET | Energy Transfer LP | 0% | — | 不变 |
| 5 | ✓ | Ovascience INC | 0% | — | 不变 |
| 6 | ✓ | Ampliphi Biosciences | 0% | +36.98% | 加仓 |
| 7 | ET | Energy Transfer LP | 0% | — | 不变 |
| 8 | NSUSD | Nustar Energy LP | 0% | — | 不变 |
| 9 | TCP | Tc Pipelines LP | 0% | — | 不变 |
| 10 | GEL | Genesis Energy L.p. | -0.1% | — | 不变 |
| 11 | ✓ | Oragenics INC | -0.1% | — | 不变 |
| 12 | ✓ | Transgenomic INC | -0.1% | — | 不变 |
| 13 | ✓ | Synthetic Biologics INC | -0.2% | — | 不变 |
| 14 | ✓ | Alaunos Therapeutics INC | -0.2% | — | 不变 |
| 15 | EPD | Enterprise Products Partners | -0.3% | — | 不变 |
| 16 | ✓ | Fibrocell Science INC | -0.4% | — | 不变 |
| 17 | ✓ | Avexis INC | — | EXIT | 清仓 |
| 18 | MMLP | Martin Midstream Partners LP | — | EXIT | 清仓 |